These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31618032)

  • 1. Structure-Activity Relationships of
    Rajput S; McLean KJ; Poddar H; Selvam IR; Nagalingam G; Triccas JA; Levy CW; Munro AW; Hutton CA
    J Med Chem; 2019 Nov; 62(21):9792-9805. PubMed ID: 31618032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
    Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C
    ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
    Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
    J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Coyne AG; McLean KJ; James GG; Levy CW; Marino LB; de Carvalho LP; Chan DS; Hudson SA; Surade S; Leys D; Munro AW; Abell C
    J Med Chem; 2016 Apr; 59(7):3272-302. PubMed ID: 27002486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.
    McLean KJ; Cheesman MR; Rivers SL; Richmond A; Leys D; Chapman SK; Reid GA; Price NC; Kelly SM; Clarkson J; Smith WE; Munro AW
    J Inorg Biochem; 2002 Sep; 91(4):527-41. PubMed ID: 12237220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis.
    Davis HJ; Kavanagh ME; Balan T; Abell C; Coyne AG
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3735-40. PubMed ID: 27287372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
    Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
    J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450.
    Leys D; Mowat CG; McLean KJ; Richmond A; Chapman SK; Walkinshaw MD; Munro AW
    J Biol Chem; 2003 Feb; 278(7):5141-7. PubMed ID: 12435731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions.
    Duffell KM; Hudson SA; McLean KJ; Munro AW; Abell C; Matak-Vinković D
    Anal Chem; 2013 Jun; 85(12):5707-14. PubMed ID: 23675886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
    Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
    Child SA; Ghith A; Bruning JB; Bell SG
    J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen.
    McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
    Ortiz de Montellano PR
    J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QM/MM study of the C-C coupling reaction mechanism of CYP121, an essential cytochrome p450 of Mycobacterium tuberculosis.
    Dumas VG; Defelipe LA; Petruk AA; Turjanski AG; Marti MA
    Proteins; 2014 Jun; 82(6):1004-21. PubMed ID: 24356896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.